The effect of anti-L-selectin (aselizumab) in multiple traumatized patients - Results of a phase II clinical trial

Andreas Seekamp, Martijn Van Griensven, Erwin Dhondt, Michael Diefenbeck, Ignace Demeyer, Guy Vundelinckx, Norbert Haas, Ulrich Schaechinger, Laura Wolowicka, Stefan Rammelt, Jan Stroobants, Ingo Marzi, Ansgar M. Brambrink, Piotr Dziurdzik, Jacek Ga̧siorowski, Heinz Redl, Michael Beckert, Jasmin Khan-Boluki

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint Dive into the research topics of 'The effect of anti-L-selectin (aselizumab) in multiple traumatized patients - Results of a phase II clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences